Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells

Pathology and Oncology Research

Volumn 15, Issue 3, 2009, Pages 335-344

  Réti, Andrea ^a   Barna, Gábor ^b   Pap, Éva ^a   Adleff, Vilmos ^a   Komlósi, Viktor ^a   Jeney, András ^b   Kralovánszky, Judit ^a   Budai, Barna ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

5 fluorouracil; Cell cycle phase; COX 2; HT 29 and HCA 7 cells; Indomethacin; NS 398

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYCLOOXYGENASE 2; FLUOROURACIL; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; SULFORHODAMINE B; THYMIDYLATE SYNTHASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE MICROSCOPY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 73449119600     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9126-9     Document Type: Article

References (45)

1. SM Prescott FA Fitzpatrick 2000 Cyclooxygenase-2 and carcinogenesis Biochim Biophys Acta 1470 69 78
2. N Kawai M Tsujii S Tsuji 2002 Cyclooxygenases and colon cancer Prostaglandins Other Lipid Mediat 68-69 187 196 10.1016/S0090-6980(02)00030-8 12432918 (Pubitemid 35247396)
3. S Zha V Yegnasubramanian WG Nelson, et al. 2004 Cyclooxygenases in cancer: progress and perspective Cancer Lett 215 1 20 10.1016/j.canlet.2004.06. 014 1:CAS:528:DC%2BD2cXnslGhsr0%3D 15374627 (Pubitemid 39221453)
4. MK Rishikesh SS Sadhana 2003 Prostaglandins and cyclooxygenase: Their probable role in cancer Indian J Pharmacol 35 3 12 1:CAS:528: DC%2BD3sXhs1ynsL4%3D
5. G Weckbecker 1991 Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators Pharmac Ther 50 367 424 10.1016/0163-7258(91)90051-M 1:CAS:528:DyaK38XnsFCksg%3D%3D
6. I Petak DM Tillman JA Houghton 2000 p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines Clin Cancer Res 6 4432 4441 1:CAS:528:DC%2BD3cXovVSnsr4%3D 11106264
7. D Adeyemo F Imtiaz S Toffa, et al. 2001 Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein Cancer Lett 164 77 84 10.1016/S0304-3835(00)00720-5 1:CAS:528:DC%2BD3MXpsFCksA%3D%3D 11166918 (Pubitemid 32144992)
8. F Ponthan M Wickström H Gleissman, et al. 2007 Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo Clin Cancer Res 13 1036 1044 10.1158/1078-0432.CCR- 06-1908 1:CAS:528:DC%2BD2sXhsVyrsr8%3D 17289900 (Pubitemid 46340383)
9. D Mazhar R Ang J Waxman 2006 COX inhibitors and breast cancer Br J Cancer 94 346 350 10.1038/sj.bjc.6602942 1:CAS:528:DC%2BD28XhtFGqs7k%3D 16421592 (Pubitemid 43237558)
10. S Mercadante 2001 The use of anti-inflammatory drugs in cancer pain Cancer Treat Rev 27 51 61 10.1053/ctrv.2000.0192 1:CAS:528:DC%2BD3MXitlKht7Y%3D 11237777 (Pubitemid 32229685)
11. HA Minter JW Eveson S Huntley, et al. 2003 The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis Clin Cancer Res 9 1885 1897 1:CAS:528:DC%2BD3sXjsFeitb4%3D 12738747
12. YC Ou CR Yang CL Cheng, et al. 2007 Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT Eur J Pharmacol 563 49 60 10.1016/j.ejphar.2007.01.071 1:CAS:528:DC%2BD2sXksV2ktLg%3D 17341418 (Pubitemid 46602228)
13. M Zhang Y Abe T Matsushima, et al. 2005 Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway Leuk Lymphoma 46 425 433 10.1080/10428190400015691 1:CAS:528: DC%2BD2cXhtFCqurrK 15621834 (Pubitemid 40220401)
14. S Aggarwal N Taneja L Lin, et al. 2000 Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression Neoplasia 2 346 356 10.1038/sj.neo.7900097 1:CAS:528:DC%2BD3cXntVCjtbs%3D 11005569
15. J Shao H Sheng H Inoue, et al. 2000 Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells J Biol Chem 275 33951 33956 10.1074/jbc.M002324200 1:CAS:528:DC%2BD3cXnvVyjtLk%3D 10930401 (Pubitemid 30808623)
16. E Hitre B Budai V Adleff, et al. 2005 Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil Pharmacogenet Genomics 15 723 730 10.1097/01.fpc. 0000175598.42141.59 1:CAS:528:DC%2BD2MXpslahtb0%3D 16141798
17. P Frosst HJ Blom R Milos, et al. 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 111 113 10.1038/ng0595-111 1:CAS:528:DyaK2MXlsVymt78%3D 7647779
18. C Katona F Tímár A Jeney, et al. 1999 Modulation of 5-fluorouracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activities Anticancer Drugs 10 561 567 10.1097/00001813-199907000-00008 1:CAS:528:DyaK1MXls1ans74%3D 10885904
19. VE Stubbs P Schratl A Hartnell, et al. 2002 Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils J Biol Chem 277 26012 26020 10.1074/jbc.M201803200 1:CAS:528:DC%2BD38XlsFKrsb0%3D 11980903 (Pubitemid 34967083)
20. J Barnett J Chow D Ives 1994 Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system Biochim Biophys Acta 1209 130 139 1:CAS:528: DyaK2MXitlWlsLk%3D 7947975
21. JA Sánchez-Alcázar DA Bradbury L Pang AJ Knox 2003 Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways Lung Cancer 40 33 44 10.1016/S0169-5002(02)00530-5 12660005 (Pubitemid 36344064)
22. JH Han MS Roh CH Park, et al. 2004 Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts Mech Ageing Dev 125 359 366 10.1016/j.mad.2004.02.002 1:CAS:528:DC%2BD2cXjvVeqsbs%3D 15130753 (Pubitemid 38595187)
23. J Kralovánszky C Katona A Jeney, et al. 1999 5-ethyl-2'- deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil J Cancer Res Clin Oncol 125 675 684 10.1007/s004320050333 10592100
24. A Beck MC Etienne S Chéradame, et al. 1994 A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil Eur J Cancer 30A 1517 1522 10.1016/0959-8049(94)00216-R 1:CAS:528:DyaK2MXit1Wls7o%3D 7833111 (Pubitemid 24343014)
25. MC Etienne K Ilc JL Formento, et al. 2004 Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity Br J Cancer 90 526 534 10.1038/sj.bjc.6601523 1:CAS:528:DC%2BD2cXksl2mtw%3D%3D 14735204 (Pubitemid 38250655)
26. CP Duffy CJ Elliott RA O'Connor, et al. 1998 Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs) Eur J Cancer 34 1250 1259 10.1016/S0959-8049(98)00045-8 1:CAS:528:DyaK1cXltlCgsro%3D 9849488 (Pubitemid 28342118)
27. A Bennett JD Gaffen PB Melhuish IF Stamford 1987 Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate Br J Pharmacol 91 229 235 1:CAS:528:DyaL2sXksFWmtr8%3D 3594078
28. M Ogino M Hanazono 1999 Indomethacin preferentially augments 5-fluorouracil cytotoxicity in Colon 26 tumors by increasing the intracellular inflow of 5-fluorouracil Int J Clin Oncol 4 22 25 10.1007/s101470050018 (Pubitemid 29117735)
29. M Ogino S Minoura 2001 Indomethacin increases the cytotoxicity of cis-platinum and 5-fluorouracil in the human uterine cervical cancer cell lines SKG-2 and HKUS by increasing the intracellular uptake of the agents Int J Clin Oncol 6 84 89 10.1007/PL00012088 1:CAS:528:DC%2BD3MXotFGgtb0%3D 11706755
30. G Totzke K Schulze-Osthoff U Jänicke 2003 Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced appoptosis independently of COX-2 inhibition Oncogene 22 8021 8030 10.1038/sj.onc.1206837 12970750 (Pubitemid 37175866)
31. G O'Callaghan J Kelly F Shanahan A Houston 2008 Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells Br J Cancer 99 3 502 512 10.1038/sj.bjc.6604490 18648368
32. M Yasumaru S Tsuji M Tsujii, et al. 2003 Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway Cancer Res 63 20 6726 6734 1:CAS:528:DC%2BD3sXosVGgu7s%3D 14583467
33. S Touhey R O'Connor S Plunkett, et al. 2002 Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition identification of novel chemotherapeutic drug resistance modulators Eur J Cancer 38 1661 1670 10.1016/S0959-8049(02)00128-4 1:CAS:528:DC%2BD38Xls1WisLs%3D 12142058 (Pubitemid 34876507)
34. S Kobayashi S Okada H Yoshida S Fujimura 1997 Indomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells Tohoku J Exp Med 181 361 370 10.1620/tjem.181.361 1:CAS:528:DyaK2sXis1eksLg%3D 9163851
35. K Eichele R Ramer B Hinz 2008 Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells Oncogene 27 3032 3044 10.1038/sj.onc.1210962 1:CAS:528:DC%2BD1cXlsFCltrY%3D 18071320 (Pubitemid 351668009)
36. Y Mizutani K Kamoi O Ukimura, et al. 2002 Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer J Urol 168 2650 2654 10.1016/S0022-5347(05)64237-1 1:CAS:528:DC%2BD38XovVehtrY%3D 12442003
37. N Smakman N Schaap CMJT Snijckers, et al. 2005 NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation Urology 66 434 440 10.1016/j.urology.2005. 02.024 16098373 (Pubitemid 41138120)
38. NR Rodrigues A Rowan ME Smith, et al. 1990 p53 mutations in colorectal cancer Proc Natl Acad Sci USA 87 7555 7559 10.1073/pnas.87.19.7555 1:CAS:528:DyaK3cXmtVKjsL0%3D 1699228 (Pubitemid 20341755)
39. Y Liu WF Bodmer 2006 Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines Proc Natl Acad Sci USA 103 976 981 10.1073/pnas.0510146103 1:CAS:528:DC%2BD28XhsVKgtL0%3D 16418264 (Pubitemid 43212207)
40. MT Yip-Schneider CJ Sweeney SH Jung, et al. 2001 Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells J Pharmacol Exp Ther 298 976 985 1:CAS:528:DC%2BD3MXmtFKmtr8%3D 11504793
41. EA Meade WL Smith DL DeWitt 1993 Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J Biol Chem 268 6610 6614 1:CAS:528:DyaK3sXkt1Sis7w%3D 8454631
42. SH Lee MY Lee HJ Han 2008 Short-period hypoxia increases mouse embryonic stem cell proliferation through cooperation of arachidonic acid and PI3K/Akt signalling pathways Cell Prolif 41 230 247 10.1111/j.1365-2184.2008.00516.x 1:CAS:528:DC%2BD1cXlt1Cku7s%3D 18336469
43. H Zhang Y Ye Z Bai S Wang 2008 The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway Dig Dis Sci 53 2195 2203 10.1007/s10620-007-0139-0 1:CAS:528: DC%2BD1cXnvFGgtbY%3D 18320325
44. T Oguri Y Bessho H Achiwa, et al. 2007 MRP8/ABCC11 directly confers resistance to 5-fluorouracil Mol Cancer Ther 6 122 127 10.1158/1535-7163.MCT-06- 0529 1:CAS:528:DC%2BD2sXmsVantQ%3D%3D 17237272 (Pubitemid 46206674)
45. ZS Chen Y Guo MG Belinsky, et al. 2005 Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11) Mol Pharmacol 67 545 557 10.1124/mol.104.007138 1:CAS:528:DC%2BD2MXhtVWrsbg%3D 15537867 (Pubitemid 40216748)